共享风险评估和缓解策略（REMS）项目在2012年有所扩展。 - Suppr

Suppr

超能文献

Shared REMS programs expanded in 2012.

作者信息

Traynor Kate

出版信息

Am J Health Syst Pharm. 2013 Feb 15;70(4):298, 303. doi: 10.2146/news130013.

DOI:10.2146/news130013

PMID:23370134

Abstract

摘要

相似文献

Shared REMS programs expanded in 2012.

Am J Health Syst Pharm. 2013 Feb 15;70(4):298, 303. doi: 10.2146/news130013.

Where are risk evaluation and mitigation strategies headed?

Am J Health Syst Pharm. 2010 Sep 15;67(18):1511. doi: 10.2146/ajhp100404.

Risk evaluation and mitigation strategies: challenges and opportunities for health-system pharmacists.

Am J Health Syst Pharm. 2010 Sep 15;67(18):1547-54. doi: 10.2146/ajhp090640.

Am J Health Syst Pharm. 2010 Sep 15;67(18):1512. doi: 10.2146/ajhp100380.

APhA 2011 REMS white paper: Summary of the REMS stakeholder meeting on improving program design and implementation.

J Am Pharm Assoc (2003). 2011 May-Jun;51(3):340-58. doi: 10.1331/JAPhA.2011.11519.

With REMS, what goes up can come down.

Am J Health Syst Pharm. 2011 May 1;68(9):783-4. doi: 10.2146/news110028.

'Dear Healthcare Professional' letters may not be effective REMS communication tool.

Am J Health Syst Pharm. 2014 Feb 1;71(3):177-8. doi: 10.2146/news140012.

Medication guides leave their REMS programs behind.

Am J Health Syst Pharm. 2012 Feb 15;69(4):272-3. doi: 10.2146/news120013.

The Food and Drug Administration risk evaluation and mitigation strategy.

J Pain Palliat Care Pharmacother. 2010 Jun;24(2):145-8. doi: 10.3109/15360281003713834.

The Food and Drug Administration Amendments Act of 2007: drug safety and health-system pharmacy implications.

Am J Health Syst Pharm. 2009 Dec 15;66(24 Suppl 7):S3-5. doi: 10.2146/ajhp090460.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Shared REMS programs expanded in 2012.

Am J Health Syst Pharm. 2013 Feb 15;70(4):298, 303. doi: 10.2146/news130013.

Where are risk evaluation and mitigation strategies headed?

Am J Health Syst Pharm. 2010 Sep 15;67(18):1511. doi: 10.2146/ajhp100404.

Risk evaluation and mitigation strategies: challenges and opportunities for health-system pharmacists.

Am J Health Syst Pharm. 2010 Sep 15;67(18):1547-54. doi: 10.2146/ajhp090640.

Am J Health Syst Pharm. 2010 Sep 15;67(18):1512. doi: 10.2146/ajhp100380.

APhA 2011 REMS white paper: Summary of the REMS stakeholder meeting on improving program design and implementation.

J Am Pharm Assoc (2003). 2011 May-Jun;51(3):340-58. doi: 10.1331/JAPhA.2011.11519.

With REMS, what goes up can come down.

Am J Health Syst Pharm. 2011 May 1;68(9):783-4. doi: 10.2146/news110028.

'Dear Healthcare Professional' letters may not be effective REMS communication tool.

Am J Health Syst Pharm. 2014 Feb 1;71(3):177-8. doi: 10.2146/news140012.

Medication guides leave their REMS programs behind.

Am J Health Syst Pharm. 2012 Feb 15;69(4):272-3. doi: 10.2146/news120013.

The Food and Drug Administration risk evaluation and mitigation strategy.

J Pain Palliat Care Pharmacother. 2010 Jun;24(2):145-8. doi: 10.3109/15360281003713834.

The Food and Drug Administration Amendments Act of 2007: drug safety and health-system pharmacy implications.

Am J Health Syst Pharm. 2009 Dec 15;66(24 Suppl 7):S3-5. doi: 10.2146/ajhp090460.